| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |